Literature DB >> 19053313

Development and characterization of new cyclodextrin polymer-based DNA delivery systems.

Virginie Burckbuchler1, Véronique Wintgens, Christian Leborgne, Sophie Lecomte, Nadine Leygue, Daniel Scherman, Antoine Kichler, Catherine Amiel.   

Abstract

In this study, we investigated whether a cyclodextrin polymer (polybetaCD) complexed with cationic adamantyl derivatives (Ada) could be used as a vector for gene delivery. DNA compaction as a function of adamantyl/DNA phosphate ratio (A/P) by this new class of vector was demonstrated using surface enhanced Raman spectroscopy, zeta potential measurements, and DNA retardation assays. Transfection data highlight the relationship between in vitro gene delivery efficiency and the combination of several physical properties of the polybetaCD/Ada/DNA polyplexes, including cationic polar headgroup valency and chemical structure of the spacer arm of Ada connectors, the adamantyl/DNA phosphate ratio (A/P) of the polybetaCD/Ada/DNA polyplexes, and the ionic strength of the medium. Finally, when associating the best formulation with a fusogenic peptide, we reached transfection levels which were of the same order as those obtained with DOTAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053313     DOI: 10.1021/bc800070f

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

1.  Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications.

Authors:  Jianxiang Zhang; Peter X Ma
Journal:  Nano Today       Date:  2010-08-01       Impact factor: 20.722

Review 2.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 3.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

4.  Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes.

Authors:  Julia Preu; Timo Jaeger; Vasil M Garamus; Thomas Gutberlet
Journal:  Eur Biophys J       Date:  2011-02-03       Impact factor: 1.733

5.  Smart DNA vectors based on cyclodextrin polymers: compaction and endosomal release.

Authors:  Véronique Wintgens; Christian Leborgne; Sonia Baconnais; Virginie Burckbuchler; Eric Le Cam; Daniel Scherman; Antoine Kichler; Catherine Amiel
Journal:  Pharm Res       Date:  2011-08-17       Impact factor: 4.200

Review 6.  Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective.

Authors:  Jianxiang Zhang; Peter X Ma
Journal:  Adv Drug Deliv Rev       Date:  2013-05-11       Impact factor: 15.470

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.